tiprankstipranks
Trending News
More News >
Evgen Pharma PLC (GB:TCF)
LSE:TCF
UK Market

Evgen Pharma (TCF) Income Statement

Compare
4 Followers

Evgen Pharma Income Statement

Last quarter (Q4 2024), Evgen Pharma's total revenue was £0.00, a decrease of -100.00% from the same quarter last year. In Q4, Evgen Pharma's net income was £-696.00K. See Evgen Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
£ 0.00£ 396.00K£ 442.00K£ 0.00£ 194.00K
Gross Profit
£ -2.11M£ 385.00K£ 429.00K£ -16.00K£ -3.19M
Operating Expenses
£ 12.00K£ 3.94M£ 5.50M£ 3.17M£ 3.38M
Depreciation and Amortization
£ 69.00K£ 11.00K£ 13.00K£ 16.00K£ 18.00K
EBITDA
£ -2.06M£ -3.55M£ -4.99M£ -3.15M£ -3.19M
Operating Income
£ -2.12M£ -3.56M£ -5.07M£ -3.19M£ -3.20M
Other Income/Expenses
£ 39.00K£ -6.00K£ 98.00K£ 22.00K£ -9.00K
Pretax Income
£ -2.08M£ -3.57M£ -5.01M£ -3.17M£ -3.21M
Net Income
£ -1.94M£ -3.14M£ -4.04M£ -2.73M£ -2.67M
Per Share Metrics
Basic EPS
£ 0.00£ -0.01£ -0.01£ -0.01£ -0.02
Diluted EPS
£ 0.00£ -0.01£ -0.01£ -0.01£ -0.02
Weighted Average Shares Outstanding
538.42M 274.89M 274.89M 274.89M 147.02M
Weighted Average Shares Outstanding (Diluted)
538.31M 274.89M 274.89M 274.89M 147.02M
Currency in GBP

Evgen Pharma Earnings and Revenue History